S&P 500

5.309,47

0,12%

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

Startseite
Investieren
Aktien
USA
NASDAQ
Synta Pharmaceuticals Corp. (MM) (SNTA)
Synta Pharmaceuticals Corp. (MM) (SNTA) News

SNTA

Synta Pharmaceuticals Corp. (MM) (SNTA)

Synta Pharmaceuticals Corp. (MM)

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SNTA

1 2 3 4 5 6 7 8 9 10 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
29/07/2016	21h13	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
29/07/2016	19h25	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
26/07/2016	23h56	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
26/07/2016	23h27	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
26/07/2016	23h27	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
26/07/2016	23h27	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
26/07/2016	23h20	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
26/07/2016	23h19	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
26/07/2016	23h19	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
26/07/2016	23h17	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
26/07/2016	21h38	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
22/07/2016	23h24	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
22/07/2016	23h23	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
22/07/2016	23h19	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
22/07/2016	23h02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
22/07/2016	17h30	GlobeNewswire Inc.	Madrigal Pharmaceuticals Completes Merger with Synta to Create Leading Cardiovascular-Metabolic Diseases and NASH Company	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
21/07/2016	22h17	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
20/07/2016	22h04	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
06/07/2016	22h28	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
01/07/2016	13h35	PR Newswire (US)	Why Investors Have These Biotech Stocks on Their Radar? - Synta Pharma, Idera Pharma, Threshold Pharma, and Viking Therapeuti...	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
14/06/2016	14h32	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
08/06/2016	22h30	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
08/06/2016	22h28	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
08/06/2016	22h15	Business Wire	Synta Announces Date and Location of Annual Meeting of Stockholders to Vote on Merger with Madrigal Pharmaceuticals	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
08/06/2016	22h03	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (definitive) (defm14a)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
03/06/2016	23h16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
02/06/2016	22h18	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
02/06/2016	22h17	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
02/06/2016	13h00	Business Wire	Synta Pharmaceuticals to Present at Upcoming Investor Conferences in June	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)
27/05/2016	14h20	PR Newswire (US)	Why Biotech Stocks Fascinate Investors? - Synta Pharma, CTI BioPharma, Lpath, and Heat Biologics	NASDAQ:SNTA	Synta Pharmaceuticals Corp. (MM)